TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32130142

Group type: EXPERIMENTAL
Intervention: Major self-management support intervention (personal email contacts with a dementia nurse, online videos, and e-bulletins)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Medium intervention (online videos and e-bulletins)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Minor intervention (e-bulletins only)
Number of subjects: 81
Study: 35262646

Group type: EXPERIMENTAL
Intervention: Upadacitinib 15 mg
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Upadacitinib (both doses)
Number of subjects: 1609
Study: 33857028

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN) 50 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33164066

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by chemoradiotherapy (Arm B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chemoradiotherapy with concurrent S-1 (Arm A)
Number of subjects: 100
Study: 32578813

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) group (allowed to ingest a carbohydrate-rich beverage two hours before surgery)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fasting group (absolute fasting after 00:00)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 34599686

Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagal nerve stimulation (taVNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 33707991

Group type: COMPARATOR
Intervention: Active Play (CON)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Locomotor Skills Guided Active Play (LOC)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Object Control Skills Guided Active Play (OC)
Number of subjects: 52
Study: 32900672

Group type: EXPERIMENTAL
Intervention: Adjectives 'positive' vs. 'negative' (n=566)
Number of subjects: 1131

Group type: EXPERIMENTAL
Intervention: Adjectives 'abnormal' vs. 'normal' (n=565)
Number of subjects: 1131

Group type: COMPARATOR
Intervention: Comparison of 'positive' vs. 'negative' and 'abnormal' vs. 'normal'
Number of subjects: 1131
Study: 32301388

Group type: EXPERIMENTAL
Intervention: Propofol combined with low-dose ketamine (0.25mg/kg propofol + 0.15mg/kg ketamine)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol (0.25mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (0.9% NaCl)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 32473378

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Tertile 3 AnxA1 levels
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Tertile 4 congestion score
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Tertiles 2 and 3 AnxA1 levels
Number of subjects: 275
Study: 616733476

Group type: EXPERIMENTAL
Intervention: CD symptoms plus a diagnostic label and description of LPE traits
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: CD symptoms plus a description of LPE traits and a 'psychopath' label
Number of subjects: 326

Group type: COMPARATOR
Intervention: CD symptoms only
Number of subjects: 326

Group type: COMPARATOR
Intervention: CD symptoms plus a diagnostic label
Number of subjects: 326
Study: 34121665

Group type: EXPERIMENTAL
Intervention: CFLU mHealth tool
Number of subjects: 17
Study: 32361667

Group type: EXPERIMENTAL
Intervention: Observer perspective (third-person)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Field perspective (first-person)
Number of subjects: 112
Study: 35409646

Group type: EXPERIMENTAL
Intervention: Individualised exercise prescription (n = 24)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standardised exercise prescription (n = 25)
Number of subjects: 49
Study: 32115325

Group type: EXPERIMENTAL
Intervention: Youth Aware of Mental Health (YAM) intervention
Number of subjects: 1878
Study: 36095039

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Book-listening regimen
Number of subjects: 40
Study: 33561882

Group type: EXPERIMENTAL
Intervention: Nonparametric statistical model for randomization tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Covariate imbalance
Number of subjects: 0
Study: 36050726

Group type: EXPERIMENTAL
Intervention: Machine learning methods applied to PROMs datasets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classification task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalizable machine learning pipelines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PROMs
Number of subjects: 0
Study: 34130029

Group type: EXPERIMENTAL
Intervention: BALANCE Program
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control group (conventional nutrition advice)
Number of subjects: 369
Study: 36229975

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Baseline sCD163 ≤ 500 pg/ml
Number of subjects: 193
Study: 32903063

Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nasal zolmitriptan
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sumatriptan 50 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sumatriptan 100 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Various drugs
Number of subjects: 22
Study: 32435057

Group type: EXPERIMENTAL
Intervention: 6-month exercise programme of tailored aerobic and resistance training
Number of subjects: 131

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131
Study: 33742252

Group type: EXPERIMENTAL
Intervention: Combined regimen (carboxy therapy + intralesional corticosteroids)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intralesional corticosteroids (ILC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carboxy therapy
Number of subjects: 30
Study: 33710163

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 40
Study: 32166395

Group type: EXPERIMENTAL
Intervention: Unilateral subcostal transversus abdominis plane (TAP) block with 20 mL 0.25% bupivacaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local anesthetic infiltration at port sites with 20 mL 0.25% bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 33941032

Group type: EXPERIMENTAL
Intervention: Pharmacist-led telemedicine counseling every 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 90
Study: 34133820

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg every 8 hours for 5 days)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Ketorolac (10 mg every 8 hours for 5 days)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Diclofenac (50 mg every 8 hours for 5 days)
Number of subjects: 198
Study: 32909259

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study: 35584930

Group type: EXPERIMENTAL
Intervention: Age at menarche of 9‐12 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 13 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 14 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 16 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 17 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 18‐20 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 40‐59 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of 60‐79 years
Number of subjects: 54937

Group type: EXPERIMENTAL
Intervention: Age at menarche of early age
Number of subjects: 54937
Study: 34481881

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cathodal tDCS (c‐tDCS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 58
Study: 34479714

Group type: EXPERIMENTAL
Intervention: Patients who developed AWS
Number of subjects: 497819

Group type: COMPARATOR
Intervention: Patients who did not develop AWS
Number of subjects: 497819

Group type: EXPERIMENTAL
Intervention: Risk factors for AWS
Number of subjects: 497819

Group type: EXPERIMENTAL
Intervention: Model for predicting AWS
Number of subjects: 497819
Study: 32093628

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 1978

Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg and 200 mg
Number of subjects: 1978
Study: 33835089

Group type: EXPERIMENTAL
Intervention: Gait training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (surgery only)
Number of subjects: 20
Study: 34541612

Group type: EXPERIMENTAL
Intervention: Sorafenib alone or following selective internal radiation therapy (SIRT)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: High gadoxetic acid uptake
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Child–Pugh class
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Tumor diameter
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: ALBI grade
Number of subjects: 312
Study: 33742323

Group type: EXPERIMENTAL
Intervention: PlasmaBlade® dissection
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (traditional electrocautery)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PlasmaBlade® dissection and Control (traditional electrocautery)
Number of subjects: 20
Study: 32716540

Group type: EXPERIMENTAL
Intervention: Alkaline detergent immersion followed by multi-enzyme detergent ultrasonic cleaning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other cleaning procedures (not specified)
Number of subjects: 0
Study: 35290813

Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide vaccine (PPV)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1001
Study: 32896644

Group type: EXPERIMENTAL
Intervention: one tDCS stimulation per day
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: two tDCS stimulations per day
Number of subjects: 93

Group type: COMPARATOR
Intervention: Sham group: one sham tDCS stimulation per day
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: tDCS (Group I and II)
Number of subjects: 93
Study: 35220556

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33861441

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg) and famotidine (40 mg) daily for 1 month
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo and famotidine (40 mg)
Number of subjects: 75
Study: 37434220

Group type: EXPERIMENTAL
Intervention: Intermittently scanned continuous glucose monitor (isCGM) (FreestyleLibre2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-monitored blood glucose (SMBG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: isCGM
Number of subjects: 0

Group type: COMPARATOR
Intervention: isCGM and SMBG
Number of subjects: 0
Study: 34813645

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Demineralized bone xenograft (DMBM)
Number of subjects: 14
Study: 33270945

Group type: EXPERIMENTAL
Intervention: Acute phenylalanine/tyrosine depletion in the LFS group
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Acute phenylalanine/tyrosine depletion in both diet groups
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Baseline peripheral dopamine precursor availability (pDAP) in the HFS group
Number of subjects: 31
Study: 34782918

Group type: EXPERIMENTAL
Intervention: Machine learning-based random forest model
Number of subjects: 286
Study: 32702699

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous alteplase
Number of subjects: 2526

Group type: COMPARATOR
Intervention: Standard-dose intravenous alteplase
Number of subjects: 2526

Group type: EXPERIMENTAL
Intervention: Background features of brain frailty (atrophy, white matter change, old infarcts)
Number of subjects: 2526
Study: 616702026

Group type: EXPERIMENTAL
Intervention: Strength training program using free weights (FW)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Strength training program using elastic tubing (ET)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 62
Study: 36910899

Group type: EXPERIMENTAL
Intervention: Intrarectal local anesthesia with 20 mL of heated (40°C) 2% lidocaine gel (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Periprostatic nerve block (PNB) (n = 50)
Number of subjects: 100
Study: 33394849

Group type: EXPERIMENTAL
Intervention: Direct health education by phone calls
Number of subjects: 560

Group type: COMPARATOR
Intervention: No phone call (control group)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Phone call group
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Young FDRs
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: FDRs living within 200 km of the hospital
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Probands with moderate to severe visual impairment
Number of subjects: 560
Study: 34404334

Group type: EXPERIMENTAL
Intervention: Informal help-seeking behaviors (HSBs)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Informal HSB
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Formal HSB
Number of subjects: 390
Study: 34635066

Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 50
Study: 32838982

Group type: EXPERIMENTAL
Intervention: esketamine/SNP
Number of subjects: 20

Group type: COMPARATOR
Intervention: esketamine/placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: racemic ketamine/SNP
Number of subjects: 20

Group type: COMPARATOR
Intervention: racemic ketamine/placebo
Number of subjects: 20
Study: 33334936

Group type: EXPERIMENTAL
Intervention: Maintenance use to participants and HCPs (n=87)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Maintenance use to participants (n=88)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Maintenance and rescue use to participants and HCPs (n=88)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Maintenance and rescue use to participants (n=88)
Number of subjects: 437

Group type: COMPARATOR
Intervention: No feedback (control) (n=86)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Data on rescue use
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: All study arms
Number of subjects: 437
Study: 35058418

Group type: EXPERIMENTAL
Intervention: Novel fitting algorithm
Number of subjects: 103

Group type: COMPARATOR
Intervention: Traditional method (optometrist's calculation)
Number of subjects: 103
Study: 33080088

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 2859

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2859
Study: 35835616

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 3
Study: 33933916

Group type: EXPERIMENTAL
Intervention: BVDV antibody competitive-ELISA assay
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 339
Study: 35442901

Group type: EXPERIMENTAL
Intervention: Spiking neural networks (SNNs) with a double recurrent network imitating the hippocampus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebellum-inspired module for radial contact response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Block-based feedforward network for movement planning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controller and planner for generating teaching signals
Number of subjects: 0
Study: 34358819

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35803469

Group type: EXPERIMENTAL
Intervention: Camostat mesylate 300 mg three times daily in a fasted state
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Camostat mesylate
Number of subjects: 90
Study: 32828877

Group type: EXPERIMENTAL
Intervention: High-viscosity eye drops
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Low-viscosity eye drops
Number of subjects: 80

Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 80
Study: 32738206

Group type: EXPERIMENTAL
Intervention: Exercise training program (supervised training) from 3rd to 6th months after surgery
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Exercise training program
Number of subjects: 58
Study: 35482790

Group type: EXPERIMENTAL
Intervention: Blood Transfusion (BT, n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (CON, n = 24)
Number of subjects: 48
Study: 33914570

Group type: EXPERIMENTAL
Intervention: MST‐PSB
Number of subjects: 48

Group type: COMPARATOR
Intervention: UCS
Number of subjects: 48
Study: 33180187

Group type: EXPERIMENTAL
Intervention: Retained urinary catheter (UC)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Non-retained urinary catheter (non-UC)
Number of subjects: 230
Study: 34393696

Group type: EXPERIMENTAL
Intervention: cyclophosphamide + fish oil
Number of subjects: 237

Group type: COMPARATOR
Intervention: cyclophosphamide + placebo
Number of subjects: 237
Study: 33840359

Group type: EXPERIMENTAL
Intervention: Plyometric conditioning activity (3 sets of 5 countermovement jumps)
Number of subjects: 14
Study: 32229229

Group type: EXPERIMENTAL
Intervention: Supervised physical training (PT) group, n = 22, received home‐based supervised muscle strength and endurance training in twice‐weekly 60‐min sessions for 12 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Supervised physical training (PT) group, n = 22
Number of subjects: 44

Group type: COMPARATOR
Intervention: Unsupervised activity booklet group, n = 22
Number of subjects: 44
Study: 33554565

Group type: EXPERIMENTAL
Intervention: AI autoverification system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rule-based engine
Number of subjects: 0
Study: 34498207

Group type: EXPERIMENTAL
Intervention: Rapid EVD wean protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gradual EVD wean protocol
Number of subjects: 0
Study: 32285983

Group type: EXPERIMENTAL
Intervention: Fractionated frequency-doubled 1064/532 nm picosecond Nd:YAG laser (FPL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fractionated 1927 nm thulium fiber laser (TFL)
Number of subjects: 20
Study: 35267491

Group type: EXPERIMENTAL
Intervention: mFOLFOX6 + bevacizumab (arm A)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: FOLFIRI + bevacizumab (arm B)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Patients with pathological response (PR) among all CRLMs
Number of subjects: 65
Study: 35351723

Group type: EXPERIMENTAL
Intervention: Exercise at time of peak hyperglycaemia (ExPeak, personalised)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Exercise not at time of peak hyperglycaemia (NonPeak)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waitlist control (WLC, standard care)
Number of subjects: 70
Study: 33536190

Group type: EXPERIMENTAL
Intervention: PI3Kβ inhibitor AZD8186
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AKT inhibitor MK-2206
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MEK inhibitor selumetinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: selumetinib (clinical trial)
Number of subjects: 0
Study: 32928788

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 35852576

Group type: EXPERIMENTAL
Intervention: SoC+CT
Number of subjects: 862

Group type: COMPARATOR
Intervention: SoC
Number of subjects: 862
Study: 33367691

Group type: EXPERIMENTAL
Intervention: teen Mental Health First Aid (teenMHFA) program
Number of subjects: 979
Study: 34978662

Group type: EXPERIMENTAL
Intervention: Hybrid decision support system using Artificial Intelligence for low-risk prescriptions
Number of subjects: 420

Group type: COMPARATOR
Intervention: High-risk prescriptions
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Hybrid decision support system
Number of subjects: 420

Group type: COMPARATOR
Intervention: Clinical Decision Support System (CDSS)
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Hybrid decision support tool
Number of subjects: 420
Study: 34195574

Group type: EXPERIMENTAL
Intervention: Afatinib (40 mg per day)
Number of subjects: 795

Group type: COMPARATOR
Intervention: Erlotinib (150 mg per day)
Number of subjects: 795
Study: 35705502

Group type: EXPERIMENTAL
Intervention: DIZ101 (intravenous infusion of levodopa/carbidopa)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DIZ102 (subcutaneous infusion of levodopa/carbidopa)
Number of subjects: 20

Group type: COMPARATOR
Intervention: LCIG (intestinal infusion of levodopa/carbidopa)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DIZ102
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DIZ101 and DIZ102
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All treatments (DIZ101, DIZ102, LCIG)
Number of subjects: 20
Study: 32108898

Group type: EXPERIMENTAL
Intervention: Rapid Polymyxin™ NP (RP‐NP) for CRE
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Rapid Polymyxin™ Acinetobacter (RP‐AB) for CRAB
Number of subjects: 163

Group type: COMPARATOR
Intervention: Broth microdilution (BMD)
Number of subjects: 163
Study: 35475975

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) decoction, administered twice a day for at least 3 and up to 24 months.
Number of subjects: 338
Study: 34266456

Group type: EXPERIMENTAL
Intervention: Leukocyte and platelet-rich fibrin (L-PRF) applied on ulcer beds during twice-weekly dressing changes
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual care (saline dressings only) during twice-weekly dressing changes
Number of subjects: 130
Study: 35266830

Group type: EXPERIMENTAL
Intervention: hNB001 (20 mg to 400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: hNB001
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0